Download | < Back |
24 Jan 2022 | |
With reference to above mentioned subject, we would like to inform you that there is typographical error in point no. 6 of notes to Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and nine months ended on December 31, 2021. The respective correction does not have any impact on financial figure/results/XBRL. | |
View all announcements for Tatva Chintan Pharma Chem Ltd | Source: BSE India |